Transformative Open Access agreement with the University of California
Our cost-neutral transformative agreement with the University of California runs from 1 January 2021 to 31 December 2023.
The agreement covers Open Access publishing in The Company of Biologists’ three hybrid journals (Development, Journal of Cell Science and Journal of Experimental Biology) and two Open Access journals (Disease Models & Mechanisms and Biology Open).
Corresponding authors at all ten UC campuses can publish an uncapped number of research articles immediately Open Access. Researchers on all UC campuses also have unlimited access to Development, Journal of Cell Science and Journal of Experimental Biology and their archives dating back to 1853.
Under the agreement, the UC libraries will automatically pay the first $1,000 of the Open Access fee, or article processing charge (APC), for all UC authors who choose to publish in one of The Company of Biologists’ journals. Authors are asked to pay the remainder if they have research funds available to do so. Authors who do not have research funds available can request full funding of the APC from the libraries. This ensures that lack of research funds does not present a barrier for UC authors who wish to publish Open Access in The Company of Biologists’ journals.
- See full information (including a guide for authors and details about the payment process) on the University of California website.
- Read the announcement.
Any questions? Contact us
Participating UC campuses
- UC Berkeley
- UC Davis
- UC Irvine
- UCLA
- UC Merced
- UC Riverside
- UC San Diego
- UC San Francisco
- UC Santa Barbara
- UC Santa Cruz
What authors at participating institutions say:
Professor David Schaffer, University of California at Berkeley, USA
Read Professor David Schaffer's article in Development
Alex Duman, California, Irvine, USA
Read Alex Duman’s article in Journal of Experimental Biology
Professor Joel Rothman, University of California, Santa Barbara, USA
Read Professor Joel Rothman’s article in Development
Assistant Professor Li-En Jao, UC Davis School of Medicine, USA

Read Assistant Professor Li-En Jao’s article in Journal of Cell Science